BRIEF-ACADIA Pharma surges in premarket after Parkinson's drug trial results

NEW YORK Tue Nov 27, 2012 8:05am EST

NEW YORK Nov 27 (Reuters) - ACADIA Pharmaceuticals Inc : * Acadia Pharma surges 145.7 percent to $5.65 in premarket after company said its antipsychotic drug for Parkinson's disease succeeded in meeting the primary goal and key secondary goals of a pivotal late stage clinical trial

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.